Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 2 (2005), Issue 9 (September)

1. Health-risk behaviours among adolescent survivors of childhood cancer.
   Pediatr Blood Cancer, 45(5): 706-15. [Abstract] [Full-text]
2. An epidemiological study on alcohol/drugs related fatal traffic crash cases of deceased drivers in Hong Kong between 1996 and 2000.
   Forensic Sci Int, 153(2): 196-201. [Abstract] [Full-text]
3. A Multihealth Behavior Intervention Integrating Physical Activity and Substance Use Prevention for Adolescents.
   Prev Sci. [Abstract] [Full-text]
4. Prenatal alcohol and drug exposures in adoption.
   Pediatr Clin North Am, 52(5): 1369-93, vii. [Abstract] [Full-text]
5. CYP2C-catalyzed delta9-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoin.
   Biochem Pharmacol, 70(7): 1096-103. [Abstract] [Full-text]
6. A prospective study of risk and protective factors for substance use among impoverished women living in temporary shelter settings in Los Angeles County.
   Drug Alcohol Depend, 80(1): 35-43. [Abstract] [Full-text]
7. Factors associated with the transition from abuse to dependence among substance abusers: implications for a measure of addictive liability.
   Drug Alcohol Depend, 80(1): 1-14. [Abstract] [Full-text]
8. Prevalence of abuse of alcohol and other drugs among injured drivers presenting to the emergency department of the University Hospital of Modena, Italy.
   Drug Alcohol Depend, 80(1): 135-8. [Abstract] [Full-text]
9. Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons.
   J Neurosci, 25(37): 8432-8. [Abstract] [Full-text]
10. Endocannabinoids and liver disease--review.
    Liver Int, 25(5): 921-6. [Abstract] [Full-text]
11. The P3 in 'ecstasy' polydrug users during response inhibition and execution.
    J Psychopharmacol, 19(5): 504-12. [Abstract] [Full-text]
12. Cannabis as a precipitant of cardiovascular emergencies.
    Int J Cardiol, 104(2): 230-2. [Abstract] [Full-text]
13. Genetic and environmental influences on illicit drug use and tobacco use across birth cohorts.
    Psychol Med, 35(9): 1349-56. [Abstract] [Full-text]
14. Acute delta9-tetrahydrocannabinol-induced deficits in reversal learning: neural correlates of affective inflexibility.
    Neuropsychopharmacology, 30(10): 1895-905. [Abstract] [Full-text]
15. Hallucinogen persisting perception disorder after psilocybin consumption: a case study.
    Eur Psychiatry, 20(5): 458-60. [Abstract] [Full-text]
16. Lung bullae and pulmonary fibrosis associated with marijuana smoking.
    Australas Radiol, 49(5): 411-4. [Abstract] [Full-text]
17. Cannabis use in sickle cell disease: a questionnaire study.
    Br J Haematol, 131(1): 123-8. [Abstract] [Full-text]
18. Trends in ecstasy use in the United States from 1995 to 2001: comparison with marijuana users and association with other drug use.
    Exp Clin Psychopharmacol, 13(3): 244-52. [Abstract] [Full-text]
19. Adolescent substance use outcomes in the raising healthy children project: a two-part latent growth curve analysis.
    J Consult Clin Psychol, 73(4): 699-710. [Abstract] [Full-text]
20. Adolescent and parent alliance and treatment outcome in multidimensional family therapy.
    J Consult Clin Psychol, 73(4): 689-98. [Abstract] [Full-text]
21. Evaluation of herbal dietary supplements marketed on the internet for recreational use.
    Ann Pharmacother, 39(10): 1634-9. [Abstract] [Full-text]
22. Plant, Synthetic, and Endogenous Cannabinoids in Medicine.
    Annu Rev Med. [Abstract] [Full-text]
23. Neuropsychiatric Alterations in MDMA Users: Preliminary Findings.
    Ann N Y Acad Sci, 1053: 20-7. [Abstract] [Full-text]
24. The Insight-Adherence-Abstinence triad: An integrated treatment focus for cannabis-using first-episode schizophrenia patients.
    Bull Menninger Clin, 69(3): 220-36. [Abstract] [Full-text]
25. Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival.
    Amyotroph Lateral Scler Other Motor Neuron Disord, 6(3): 182-4. [Abstract] [Full-text]
26. The Adolescent Cannabis Check-Up: Feasibility of a brief intervention for young cannabis users.
    J Subst Abuse Treat, 29(3): 207-13. [Abstract] [Full-text]
27. Teacher connectedness and health-related outcomes among detained adolescents.
    J Adolesc Health, 37(4): 337. [Abstract] [Full-text]
28. Medications development: successes and challenges.
    Pharmacol Ther, 108(1): 94-108. [Abstract] [Full-text]
29. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis.
    Neurology, 65(6): 812-9. [Abstract] [Full-text]
30. Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence.
    Addiction, 100(10): 1518-25. [Abstract] [Full-text]
31. Reducing bias in telephone survey estimates of the prevalence of drug use: a randomized trial of telephone audio-CASI.
    Addiction, 100(10): 1432-44. [Abstract] [Full-text]
32. An affective-motivational model of marijuana and alcohol problems among college students.
    Psychol Addict Behav, 19(3): 326-34. [Abstract] [Full-text]
33. A rapid situation assessment of drug use in Papua New Guinea.
    Drug Alcohol Rev, 24(1): 79-82. [Abstract] [Full-text]
34. Recreational drug use within the employees of the mariculture and seafood industry in South Australia.
    Drug Alcohol Rev, 24(1): 67-8. [Abstract] [Full-text]
35. Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs.
    Drug Alcohol Rev, 24(1): 39-48. [Abstract] [Full-text]
36. Correlates of Ecstasy use in middle age and beyond.
    Drug Alcohol Rev, 24(1): 33-8. [Abstract] [Full-text]
37. Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops.
    Addict Biol, 10(2): 171-80. [Abstract] [Full-text]
38. Low efficacy of non-opioid drugs in opioid withdrawal symptoms.
    Addict Biol, 10(2): 165-9. [Abstract] [Full-text]
39. Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure.
    J Perinatol, 25(10): 631-7. [Abstract] [Full-text]
40. The endocannabinoid system drives neural progenitor proliferation.
    FASEB J, 19(12): 1704-6. [Abstract] [Full-text]

© 2004-2008 Marijuana Research Today. All Rights Reserved.